HERON THERAPEUTICS, INC. /DE/ (HRTX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for HERON THERAPEUTICS, INC. /DE/. Most notable: 2026-08-14: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | Duarte Ira | officer | F | 3,555 | 0.38 | $1,351 |
| 2026-06-16 | Duarte Ira | officer | M | 12,500 | — | — |
| 2026-06-06 | Forbes William P | officer | M | 12,500 | — | — |
| 2026-05-06 | Hensley Mark Earl | officer | M | 125,000 | — | — |
| 2026-04-30 | Hensley Mark Earl | officer | M | 11,770 | — | — |
| 2026-04-30 | Forbes William P | officer | M | 11,770 | — | — |
| 2026-04-30 | Forbes William P | officer | M | 11,694 | — | — |
| 2026-04-30 | Duarte Ira | officer | M | 11,694 | — | — |
| 2026-04-30 | Duarte Ira | officer | M | 13,535 | — | — |
| 2026-04-30 | Collard Craig A | director | M | 34,789 | — | — |
| 2026-04-30 | Collard Craig A | director | M | 50,021 | — | — |
| 2026-04-19 | Forbes William P | officer | M | 3,874 | — | — |
| 2026-04-19 | Collard Craig A | director | M | 13,797 | — | — |
| 2026-04-19 | Duarte Ira | officer | M | 3,874 | — | — |
| 2026-04-03 | Collard Craig A | director | M | 62,500 | — | — |
| 2026-01-31 | Duarte Ira | officer | M | 11,695 | — | — |
| 2026-01-31 | Forbes William P | officer | M | 11,695 | — | — |
| 2026-01-31 | Collard Craig A | director | M | 34,789 | — | — |
| 2026-01-30 | Christian Waage | director | A | 53,960 | 0 | $0 |
| 2026-01-30 | Kaseta Michael | director | A | 53,960 | 0 | $0 |
| 2026-01-30 | Johnson Craig A | director | A | 53,960 | 0 | $0 |
| 2026-01-30 | Cusack Thomas | director | A | 53,960 | 0 | $0 |
| 2026-01-30 | Dissanaike Sharmila | director | A | 53,960 | 0 | $0 |
| 2026-01-30 | Morgan Adam | director | A | 53,960 | 0 | $0 |
| 2026-01-19 | Forbes William P | officer | M | 3,875 | — | — |
| 2026-01-19 | Duarte Ira | officer | M | 3,875 | — | — |
| 2026-01-19 | Collard Craig A | director | M | 13,797 | — | — |
| 2025-11-08 | Cusack Thomas | director | A | 37,879 | — | — |
| 2025-10-31 | Forbes William P | officer | M | 11,694 | — | — |
| 2025-10-31 | Duarte Ira | officer | M | 11,694 | — | — |
| 2025-10-31 | Collard Craig A | director | M | 34,789 | — | — |
| 2025-10-19 | Forbes William P | officer | M | 3,874 | — | — |
| 2025-10-19 | Duarte Ira | officer | M | 3,874 | — | — |
| 2025-10-19 | Collard Craig A | director | M | 13,797 | — | — |
| 2025-10-15 | Rosen David Efraim | ten percent owner | C | 946,100 | — | — |
| 2025-08-08 | Rosen David Efraim | ten percent owner | P | 2,387,225 | 1.5 | $3,580,838 |
| 2025-08-08 | Morgan Adam | director | P | 1,766,546 | 1.5 | $2,649,819 |
| 2025-07-31 | Forbes William P | officer | M | 11,695 | — | — |
| 2025-07-31 | Duarte Ira | officer | M | 11,695 | — | — |
| 2025-07-31 | Collard Craig A | director | M | 34,789 | — | — |
| 2025-07-19 | Forbes William P | officer | M | 3,874 | — | — |
| 2025-07-19 | Duarte Ira | officer | M | 3,874 | — | — |
| 2025-07-19 | Collard Craig A | director | M | 13,797 | — | — |
| 2025-06-16 | Duarte Ira | officer | M | 12,500 | — | — |
| 2025-06-06 | Forbes William P | officer | M | 12,500 | — | — |
| 2025-04-30 | Collard Craig A | director | M | 34,789 | — | — |
| 2025-04-30 | Duarte Ira | officer | M | 11,694 | — | — |
| 2025-04-30 | Forbes William P | officer | M | 11,694 | — | — |
| 2025-04-19 | Collard Craig A | director | M | 13,796 | — | — |
| 2025-04-19 | Duarte Ira | officer | M | 3,875 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.